haarlemsdagblad

Large differences in cancer drug prices, KWF calls for more transparency

Large differences in cancer drug prices, KWF calls for more transparency

KWF and the Netherlands Cancer Institute report that hospitals pay significantly different prices for the same cancer medications, with variations up to 2,800 euros per treatment. The organizations are calling for increased transparency to resolve these pricing discrepancies across the country.

Based on reporting by haarlemsdagblad. Translated and condensed by LocalHeadlines.

Related articles

Vacancy | NU.nl is looking for a social economy and healthcare reporter

Vacancy | NU.nl is looking for a social economy and healthcare reporter

NU.nl is hiring a reporter specializing in social economy and healthcare to produce original, investigative stories for its audience. The full-time position requires three years of experience and is based in Amsterdam-Duivendrecht.

End to intake freeze at Levvel, youths with severe issues can once again be admitted in Amsterdam

End to intake freeze at Levvel, youths with severe issues can once again be admitted in Amsterdam

Care organization Levvel has ended its intake freeze for Amsterdam youth following successful negotiations to secure more beds for those in need of severe residential care. While access has been restored, the municipality is demanding better coordination among providers and has initiated an independent financial audit of Levvel to ensure future stability.

House prices dip slightly again, but buying remains expensive

House prices dip slightly again, but buying remains expensive

Existing home prices in the Netherlands fell by 0.4 percent in September compared to August, though they remain 2.9 percent higher than the previous year. While the rate of price growth has slowed, houses are still significantly more expensive than they were during the peak in 2022.

Heineken must pay over 111 million euros in damages to Greek competitor

Heineken must pay over 111 million euros in damages to Greek competitor

Heineken has been ordered by an Amsterdam court to pay 111.2 million euros in damages to Greek competitor MTB. The ruling stems from the abuse of a dominant market position by Heineken's Greek subsidiary, which hindered competition through exclusive retail deals for nearly two decades.

AkzoNobel raises prices and remains on track for merger with American firm Axalta

AkzoNobel raises prices and remains on track for merger with American firm Axalta

AkzoNobel reported steady quarterly revenue of 2.5 billion euros and profit of 388 million euros, helped by price hikes and currency effects. The company is proceeding with its merger with American firm Axalta, which will result in a new entity named Axanzo and a move to the New York Stock Exchange.